PNC Financial Services Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.61K | Sell |
426
-172
| -29% | -$1.46K | ﹤0.01% | 4236 |
|
|
2025
Q1 | $4.81K | Buy |
598
+436
| +269% | +$3.51K | ﹤0.01% | 4080 |
|
|
2024
Q4 | $1.46K | Hold |
162
| – | – | ﹤0.01% | 4356 |
|
|
2024
Q3 | $1.19K | Hold |
162
| – | – | ﹤0.01% | 4408 |
|
|
2024
Q2 | $925 | Buy |
+162
| New | +$925 | ﹤0.01% | 4443 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$72 | – | 4699 |
|
|
2023
Q4 | $72 | Buy |
+8
| New | +$72 | ﹤0.01% | 4535 |
|
|
2022
Q4 | – | Sell |
-2,370
| Closed | -$18K | – | 4762 |
|
|
2022
Q3 | $18K | Buy |
2,370
+26
| +1% | +$197 | ﹤0.01% | 3484 |
|
|
2022
Q2 | $23K | Buy |
2,344
+124
| +6% | +$1.22K | ﹤0.01% | 3423 |
|
|
2022
Q1 | $27K | Sell |
2,220
-31,050
| -93% | -$378K | ﹤0.01% | 3431 |
|
|
2021
Q4 | $761K | Buy |
33,270
+30,909
| +1,309% | +$707K | ﹤0.01% | 1440 |
|
|
2021
Q3 | $52K | Sell |
2,361
-49,971
| -95% | -$1.1M | ﹤0.01% | 3044 |
|
|
2021
Q2 | $678K | Sell |
52,332
-3,881
| -7% | -$50.3K | ﹤0.01% | 1425 |
|
|
2021
Q1 | $730K | Buy |
56,213
+52,213
| +1,305% | +$678K | ﹤0.01% | 1331 |
|
|
2020
Q4 | $55K | Sell |
4,000
-25
| -0.6% | -$344 | ﹤0.01% | 2837 |
|
|
2020
Q3 | $59K | Buy |
4,025
+4,000
| +16,000% | +$58.6K | ﹤0.01% | 2643 |
|
|
2020
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 3906 |
|
|
2020
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 3888 |
|
|
2019
Q4 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 3866 |
|
|
2018
Q4 | – | Sell |
-3,000
| Closed | -$20K | – | 4029 |
|
|
2018
Q3 | $20K | Hold |
3,000
| – | – | ﹤0.01% | 3441 |
|
|
2018
Q2 | $16K | Hold |
3,000
| – | – | ﹤0.01% | 3515 |
|
|
2018
Q1 | $16K | Buy |
+3,000
| New | +$16K | ﹤0.01% | 3520 |
|
|
2017
Q1 | – | Sell |
-800
| Closed | -$2K | – | 4109 |
|
|
2016
Q4 | $2K | Buy |
+800
| New | +$2K | ﹤0.01% | 3818 |
|